Zhejiang Cheng Yi Pharmaceutical Hits Day Low Amid Price Pressure at CNY 10.53

Zhejiang Cheng Yi Pharmaceutical Co., Ltd. experienced a significant decline today, with the stock dropping by 7.58% as it reached an intraday low of CNY 10.53. This performance stands in contrast to the broader market, as the China Shanghai Composite index fell by 3.63% on the same day. Over the past week, Zhejiang Cheng Yi has seen a decrease of 10.46%, while its monthly performance reflects a decline of 8.38%. Despite these short-term challenges, the company has shown resilience over the past year, achieving a return of 20.98%, outperforming the China Shanghai Composite, which recorded a gain of 13.33%. Financially, Zhejiang Cheng Yi has reported positive results for the last three consecutive quarters, with operating cash flow reaching a high of CNY 308.94 million. The company's return on equity stands at 18.55%, supported by a price-to-book ratio of 3.30. However, its long-term growth metrics indicate a more cautious outlook, with net sales and operating profit growing at annual rates of 2.64% and 3.90%, respectively, over the last five years.